These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
523 related articles for article (PubMed ID: 20924075)
1. Double heterozygosity in the BRCA1 and BRCA2 genes in the Jewish population. Lavie O; Narod S; Lejbkowicz F; Dishon S; Goldberg Y; Gemer O; Rennert G Ann Oncol; 2011 Apr; 22(4):964-966. PubMed ID: 20924075 [TBL] [Abstract][Full Text] [Related]
2. Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families. Levy-Lahad E; Catane R; Eisenberg S; Kaufman B; Hornreich G; Lishinsky E; Shohat M; Weber BL; Beller U; Lahad A; Halle D Am J Hum Genet; 1997 May; 60(5):1059-67. PubMed ID: 9150153 [TBL] [Abstract][Full Text] [Related]
3. Differences in the characteristics of families with BRCA1 and BRCA2 mutations in Israel. Rennert G; Dishon S; Rennert HS; Fares F Eur J Cancer Prev; 2005 Aug; 14(4):357-61. PubMed ID: 16030426 [TBL] [Abstract][Full Text] [Related]
4. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Satagopan JM; Boyd J; Kauff ND; Robson M; Scheuer L; Narod S; Offit K Clin Cancer Res; 2002 Dec; 8(12):3776-81. PubMed ID: 12473589 [TBL] [Abstract][Full Text] [Related]
5. Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer. Hamel N; Kotar K; Foulkes WD BMC Med Genet; 2003 Aug; 4():7. PubMed ID: 12911837 [TBL] [Abstract][Full Text] [Related]
6. BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer. Moslehi R; Chu W; Karlan B; Fishman D; Risch H; Fields A; Smotkin D; Ben-David Y; Rosenblatt J; Russo D; Schwartz P; Tung N; Warner E; Rosen B; Friedman J; Brunet JS; Narod SA Am J Hum Genet; 2000 Apr; 66(4):1259-72. PubMed ID: 10739756 [TBL] [Abstract][Full Text] [Related]
7. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Roa BB; Boyd AA; Volcik K; Richards CS Nat Genet; 1996 Oct; 14(2):185-7. PubMed ID: 8841191 [TBL] [Abstract][Full Text] [Related]
9. Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families. Cierniková S; Tomka M; Kovác M; Stevurková V; Zajac V Neoplasma; 2006; 53(2):97-102. PubMed ID: 16575464 [TBL] [Abstract][Full Text] [Related]
10. The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. Abeliovich D; Kaduri L; Lerer I; Weinberg N; Amir G; Sagi M; Zlotogora J; Heching N; Peretz T Am J Hum Genet; 1997 Mar; 60(3):505-14. PubMed ID: 9042909 [TBL] [Abstract][Full Text] [Related]
11. High incidence of BRCA1-2 germline mutations, previous breast cancer and familial cancer history in Jewish patients with uterine serous papillary carcinoma. Biron-Shental T; Drucker L; Altaras M; Bernheim J; Fishman A Eur J Surg Oncol; 2006 Dec; 32(10):1097-100. PubMed ID: 16650962 [TBL] [Abstract][Full Text] [Related]
12. Risk factors for detecting germline BRCA1 and BRCA2 founder mutations in Ashkenazi Jewish women with breast or ovarian cancer. Hodgson SV; Heap E; Cameron J; Ellis D; Mathew CG; Eeles RA; Solomon E; Lewis CM J Med Genet; 1999 May; 36(5):369-73. PubMed ID: 10353781 [TBL] [Abstract][Full Text] [Related]
13. Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies. Antoniou AC; Pharoah PD; Narod S; Risch HA; Eyfjord JE; Hopper JL; Olsson H; Johannsson O; Borg A; Pasini B; Radice P; Manoukian S; Eccles DM; Tang N; Olah E; Anton-Culver H; Warner E; Lubinski J; Gronwald J; Gorski B; Tulinius H; Thorlacius S; Eerola H; Nevanlinna H; Syrjäkoski K; Kallioniemi OP; Thompson D; Evans C; Peto J; Lalloo F; Evans DG; Easton DF J Med Genet; 2005 Jul; 42(7):602-3. PubMed ID: 15994883 [TBL] [Abstract][Full Text] [Related]
14. The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews. Hartge P; Struewing JP; Wacholder S; Brody LC; Tucker MA Am J Hum Genet; 1999 Apr; 64(4):963-70. PubMed ID: 10090881 [TBL] [Abstract][Full Text] [Related]
15. The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel. Vazina A; Baniel J; Yaacobi Y; Shtriker A; Engelstein D; Leibovitz I; Zehavi M; Sidi AA; Ramon Y; Tischler T; Livne PM; Friedman E Br J Cancer; 2000 Aug; 83(4):463-6. PubMed ID: 10945492 [TBL] [Abstract][Full Text] [Related]
16. The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Satagopan JM; Offit K; Foulkes W; Robson ME; Wacholder S; Eng CM; Karp SE; Begg CB Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):467-73. PubMed ID: 11352856 [TBL] [Abstract][Full Text] [Related]
17. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. Struewing JP; Hartge P; Wacholder S; Baker SM; Berlin M; McAdams M; Timmerman MM; Brody LC; Tucker MA N Engl J Med; 1997 May; 336(20):1401-8. PubMed ID: 9145676 [TBL] [Abstract][Full Text] [Related]
18. Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2. Gabai-Kapara E; Lahad A; Kaufman B; Friedman E; Segev S; Renbaum P; Beeri R; Gal M; Grinshpun-Cohen J; Djemal K; Mandell JB; Lee MK; Beller U; Catane R; King MC; Levy-Lahad E Proc Natl Acad Sci U S A; 2014 Sep; 111(39):14205-10. PubMed ID: 25192939 [TBL] [Abstract][Full Text] [Related]
19. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Oddoux C; Struewing JP; Clayton CM; Neuhausen S; Brody LC; Kaback M; Haas B; Norton L; Borgen P; Jhanwar S; Goldgar D; Ostrer H; Offit K Nat Genet; 1996 Oct; 14(2):188-90. PubMed ID: 8841192 [TBL] [Abstract][Full Text] [Related]
20. Analysis of BRCA1/BRCA2 genes' contribution to breast cancer susceptibility in high risk Jewish Ashkenazi women. Distelman-Menachem T; Shapira T; Laitman Y; Kaufman B; Barak F; Tavtigian S; Friedman E Fam Cancer; 2009; 8(2):127-33. PubMed ID: 18798010 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]